Browse EX-10 agreements

SCISPARC LTD.

20 Raul Wallenberg Street, Tower A,

Tel Aviv 6971916 Israel

October 15, 2026

** **

To: L.I.A Pure Capital Ltd., a holder of a Convertible Promissory Note (the “Note”) issued on February 12, 2026

**Re: Inducement Offer to Convert Existing Convertible Promissory Note **

Dear Holder:

SCISPARC LTD. (the “Company”) is pleased to offer (this “Inducement Offer”) to you (“Holder”, “you” or similar terminology) to convert in full your Note, of which the outstanding amount (including both principal and interest) is $2,023,039.21, into ordinary shares of the Company, no par value (the “Ordinary Shares”), at a conversion price of $1.50 per Ordinary Share (the “Conversion Price”). The Ordinary Shares issuable upon conversion of the Note shall be referred to herein as the “Shares”. The resale of the Shares has been registered pursuant to an effective registration statement on Form F-3 (File No. 333-293533) (the “Registration Statement”). The Registration Statement is currently effective and, upon conversion of the Note pursuant to this letter

…

**Execution Version **

ASSET REPRESENTATIONS REVIEW AGREEMENT

among

GM FINANCIAL CONSUMER AUTOMOBILE RECEIVABLES TRUST 2026-4,

Issuer

AMERICREDIT FINANCIAL SERVICES, INC.

D/B/A GM FINANCIAL,

Servicer

and

CLAYTON FIXED INCOME SERVICES LLC,

Asset Representations Reviewer

Dated as of October 14, 2026

---

TABLE OF CONTENTS

| | | | | | | | | | | ------------------------------------------------------- | - | ------------ | : | ----------------------------------------------------------- | - | - | -: | - | | | | | | | | | | | | ARTICLE I DEFINITIONS | | | | | | | 1 | |

…

**Execution Version **

**PURCHASE AGREEMENT **

**between **

**AFS SENSUB CORP. **

**Purchaser **

**and **

**AMERICREDIT FINANCIAL SERVICES, INC. **

**D/B/A GM FINANCIAL **

**Seller **

**Dated as of October 14, 2026 **

---

**TABLE OF CONTENTS **

| | | | | | | | | | | ----------------------------------------------------------------------------- | - | ------------ | : | --------------------------------------------------------------------------- | - | ----- | -----: | ----- | | | | | | | | | | |

…

Execution Version

California Water Service Group

$125,000,000

$75,000,000 6.08% Senior Notes, Series C, due December 15, 2031 

$50,000,000 6.41% Senior Notes, Series D, due December 15, 2036

Note Purchase Agreement

Dated October 14, 2026

Table of Contents

…

Execution Version

California Water Service Company

$50,000,000 6.49% First Mortgage Bonds due 2046, Series 4 

$100,000,000 6.54% First Mortgage Bonds due 2056, Series 5

Bond Purchase Agreement

Dated October 14, 2026

Table of Contents

…

Execution Version

REGISTRATION RIGHTS AGREEMENT

** **

This Registration Rights Agreement (this “Agreement”) is made and entered into as of October 13, 2026, between Scinai Immunotherapeutics Ltd., a company organized under the laws of the State of Israel (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of October 13, 2026, between the Company and the Purchasers named therein (the “Purchase Agreement”).

The Company and each Purchaser hereby agrees as follows:

1. Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

“Advice” shall have the meaning set forth in Section 6(c).

…

Execution Version

** **

SECURITIES PURCHASE AGREEMENT

** **

This Securities Purchase Agreement (this “Agreement”) is dated as of October 13, 2026, between Scinai Immunotherapeutics Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below) and/or Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement; and

…

Execution Version

Scinai Immunotherapeutics Ltd.
Jerusalem BioPark, 2nd floor
Hadassah Ein Kerem Campus
Jerusalem, Israel
(+972) 8-930-2529

October 13, 2026

To the Holder of Warrants to Purchase Ordinary Shares Represented by American Depositary Shares Issued on April 27, 2026

Re:	Inducement Offer to Exercise Existing Warrants

Dear Holder:

…

EXECUTIVE EMPLOYMENT AGREEMENT

** **

THIS EXECUTIVE EMPLOYMENT AGREEMENT (together with the Schedules hereto, this “Agreement”) is made as of October 9, 2026 (the “Execution Date”).

BETWEEN:

** **

PINEAPPLE FINANCIAL INC., a corporation continued under the Canada Business Corporations Act, whose common shares are listed on the NYSE American LLC (“NYSE American”) under the symbol “PAPL” (the “Company”)

— and —

USMAN MAHER, an individual residing in New York, New York (the “Executive”)

RECITALS

** **

…

FORM OF EMPLOYMENT AGREEMENT

This Employment Agreement (the “Agreement”), dated as of * October 15, 2026* (the “Effective Date”), is entered into by and between Atlas Trinity Tech Limited, a company incorporated in the British Virgin Islands (the “Company” and, together with its subsidiaries, the “ATTT Group”) and Haoyuan Liu (the “Executive”).

WHEREAS, the Company and the Executive wish to enter into an employment agreement whereby the Executive will be employed by the Company in accordance with the terms and conditions stated below;

NOW, THEREFORE, the parties hereby agree as follows:

ARTICLE 1
EMPLOYMENT, DUTIES AND RESPONSIBILITIES

Section 1.01*. Employment. *The Executive shall serve as the Chief Executive Officer of the Company. The Executive hereby accepts such employment and agrees to devote substantially all of the Executive’s time and efforts to promoting the interests of the ATTT Group.

…

** **

Certain exhibits and schedules to this Agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Registrant agrees to furnish supplementally a copy of any omitted exhibit or schedule to the U.S. Securities and Exchange Commission upon request.

** **

MUTUAL STOCK PURCHASE AND ASSET EXCHANGE AGREEMENT

This Mutual Stock Purchase and Asset Exchange Agreement (this “Agreement”) is entered into as of October 14, 2026 (the “Effective Date”), by and between VIVOS THERAPEUTICS, INC., a Delaware corporation (“Vivos” or the “Purchaser”) and SOD SCIENCES, INC., a Florida corporation (“SOD” or the “Seller” and, together with Vivos, the “Parties”).

RECITALS

A. SOD owns the ReBalU Protocol, the test/treat/retest platform, the pseudohypoxia early-warning test architecture and related patent filings, a marketing agreement with American Health Associates (“AHA”), and a Memorandum of Understanding with Cleveland Clinic Weston.

…

** **

Exhibit 10.2

** **

Execution Version

** **

REGISTRATION RIGHTS AND LOCK-UP AGREEMENT

This Registration Rights and Lock-Up Agreement (this “Agreement”) is made and entered into as of October 14, 2026 and effective as of the Second Effective Time (as defined in the Business Combination Agreement (as defined below)) by and among AtlasClear Holdings, Inc., a Delaware corporation (the “Company”), and the parties listed on the signature page hereto under the heading “Holders” (each, a “Holder” and collectively, together with their respective permitted assigns, the “Holders”). Any capitalized term used but not defined herein will have the meaning ascribed to such term in the Business Combination Agreement.

RECITALS

…